Eur Respir J 2009; 33: 993–1002
DOI: 10.1183/09031936.00075708
CopyrightßERS Journals Ltd 2009
Effect of breastfeeding on asthma, lung
function and bronchial hyperreactivity in
ISAAC Phase II
G. Nagel, G. Büchele, G. Weinmayr, B. Björkstén, Y-Z. Chen, H. Wang, W. Nystad,
Y. Saraclar, L. Bråbäck, J. Batlles-Garrido, G. Garcia-Hernandez,
S.K. Weiland{ and the ISAAC Phase II Study Group
ABSTRACT: The association between breastfeeding and wheezing, lung function and atopy was
evaluated in the International Study of Asthma and Allergy in Childhood (ISAAC) Phase II.
Cross-sectional studies were performed in 27 centres in 20 countries. Information on disease
and exposure factors was collected by parental questionnaires. Data from 54,000 randomly
selected school children (aged 8–12 yrs, 31,759 with skin prick testing) and a stratified subsample
(n54,888) were used for testing the correlation of breastfeeding with bronchial hyperreactivity
and lung function. Random effect models for meta-analysis were applied to calculate combined
odds ratios (ORs).
Any breastfeeding was associated with less wheeze both in affluent (adjusted OR (ORadj) 0.87,
95% confidence interval (CI) 0.78–0.97) and nonaffluent countries (ORadj 0.80, 95% CI 0.68–0.94).
Further analyses revealed that this was true only for nonatopic wheeze in nonaffluent countries
(ORadj 0.69, 95% CI 0.53–0.90). Breastfeeding was not associated with atopic wheeze and
objective measures of allergy in both affluent and nonaffluent countries. In contrast, breastfeeding was associated with higher predicted forced expiratory volume in one second in affluent
countries only (mean ratio 1.11, 95% CI 1.02–1.20).
Breastfeeding is associated with protection against nonatopic wheeze, which becomes
particularly evident in nonaffluent countries. Overall, breastfeeding was not related to any
measure of allergy. These findings may explain some of the controversy regarding breastfeeding,
since the direction of the association with breastfeeding depends on the predominating wheeze
phenotype (e.g. atopic, nonatopic).
KEYWORDS: Asthma, atopy, breastfeeding, bronchial hyperreactivity, children, International
Study of Asthma and Allergy in Childhood
H
uman milk contains numerous components that provide the infant with both
passive protection against infections and
components that enhance the maturation of the
immune system [1]. Various possible biological
mechanisms by which breast milk may influence
atopic disease have been reported (e.g. via secretory
immunoglobulin (Ig) A, antigens, cytokines, chemokines, polyunsaturated fatty acids (PUFA) and
polyamines) [2]. In developing countries, breastfeeding reduces the incidence of infections, particularly gastrointestinal infections, while in affluent
countries the effects are less apparent [3]. Despite
numerous studies over the past 45 yrs addressing
the possible protective effects of breastfeeding
against the development of allergic disease this is
still a controversial issue [4, 5]. A study by VAN
ODIJK et al. [6] reviewed the literature on breastfeeding and the risk of allergic disease from 1966 to 2001
and concluded that breastfeeding seems to be a
protective factor for the development of atopic
disease. The inverse association was stronger in
children with atopic heredity. However, the authors
excluded many of the reviewed papers due to
noninformative findings and did not clearly differentiate between allergic and nonallergic origin of
clinical symptoms. A meta-analysis by GDALEVICH et
al. [7] included 12 studies that reported an overall
protective effect of breastfeeding on asthma, especially in children with a hereditary risk for atopy.
This article has supplementary material accessible from www.erj.ersjournals.com
EUROPEAN RESPIRATORY JOURNAL
VOLUME 33 NUMBER 5
AFFILIATIONS
For affiliations and a full list of the
ISAAC Phase II Study group
members, see Acknowledgments
section.
CORRESPONDENCE
G. Nagel
Institute of Epidemiology
Ulm University
Helmholtzstr 22
89081 Ulm
Germany
Fax: 49 7315031069
E-mail: gabriele.nagel@uni-ulm.de
Received:
May 19 2008
Accepted after revision:
December 22 2008
SUPPORT STATEMENT
The coordination and central
laboratory analyses of the European
centres were funded by the Fifth
Framework Programme of the
European Commission (QLK4-CT1999-01288; Brussels, Belgium).
ALK (Hørsholm, Denmark)
generously provided reagents for
field work in several low income
countries without charge.
STATEMENT OF INTEREST
A statement of interest for this study
can be found at
www.erj.ersjournals.com/misc/
statements.dtl
European Respiratory Journal
Print ISSN 0903-1936
Online ISSN 1399-3003
c
993
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
In a recent review, FRIEDMAN and ZEIGER [4] tried to identify
reasons for heterogeneous results for the relationship between
breastfeeding and the development of allergies and asthma.
The results of previous studies were categorised according to
neutral or allergy-inducing effects of breastfeeding [8–10] and
a protective effect of breastfeeding [11–14]. Some of the
inconsistency in the published literature may be caused by
incomplete control for potential confounding differences in the
investigated age group and outcome definition, such as the
focus on atopic dermatitis [10, 14]. Most of the epidemiological
studies included in the reviews were from affluent countries.
However, the relationship of breastfeeding to wheezing may
be different in less affluent populations with a higher burden
of infectious disease and low prevalence of allergies.
The present authors’ aim was to examine associations of
breastfeeding practice with asthma among children aged 8–
12 yrs in a large international study using data from 20
countries. By applying highly standardised methodology and
objective measurements the current authors wanted to minimise variability to differences in the way data were collected
and also explored whether atopic status or sex modifies these
associations.
MATERIALS AND METHODS
The rationale and methods of the International Study on
Allergies and Asthma in Childhood (ISAAC) Phase II have
already been described in detail elsewhere [15]. In brief,
random samples of o10 schools in a defined geographical area
were chosen and children in classes where the majority of
children were aged 9–11 yrs (no1,000 per centre) were invited
to participate. Overall, ,63,000 schoolchildren (76.4% of those
eligible) took part. Parental questionnaires identical to those
used in ISAAC Phase I [16] were used to collect data on
allergies and asthma. For the present analyses, 54,943 children
aged 8–12 yrs, from 27 centres in 20 countries were included,
with a complete set of parental responses on breastfeeding.
Exposure assessment
Data on breastfeeding were collected retrospectively by
parental questionnaire using the questions. ‘‘Was your child
ever breastfed?’’ (yes/no) and ‘‘If yes, for how long?’’
(,6 months/6–12 months/.1 yr), and the duration of breastfeeding was categorised as never breastfed, or breastfed for
,6 months or o6 months. Exclusiveness of breastfeeding was
assessed by the question. ‘‘If yes, for how long was your child
breastfed without adding other foods or juices?’’ (,2 months/
2–4 months/5–6 months/.6 months). Time of exclusive
breastfeeding was categorised as never breastfed, or breastfed
for ,2 months, 2–4 months and o4 months. The following
potential confounders were considered: sex, age of the child
(yrs), exposure to environmental tobacco smoke (ETS) at
present (‘‘Does anybody, at present, smoke inside your child’s
home?’’ (yes/no)), present bedroom sharing with other
persons (yes/no) and maternal atopic disease (‘‘has the child’s
mother ever had any of the following diseases: asthma, hay
fever or eczema?’’ (yes/no)).
The ISAAC Phase II protocol allowed objective measurements
to be performed either in the full sample or in stratified
subsamples of children [15]. Most centres invited all children
for a skin prick test (SPT), while blood samples were collected
994
VOLUME 33 NUMBER 5
G. NAGEL ET AL.
mostly in subsamples of children stratified according to their
wheezing status during the past year (,100 wheezers and 100
nonwheezers per centre). The stratified subsampling was
applied by most centres for lung function measurements and
bronchial hyperreactivity (BHR) testing. Approval of the local
ethics committees was obtained by all centres [15].
As a difference was suspected in the strength of any
association between breastfeeding and wheezing, asthma and
allergy in affluent and nonaffluent countries, the study centres
were classified into two broad categories on the basis of gross
national income (GNI) per capita, converted into USA dollars,
using the World Bank Atlas method [17]. All centres from
countries which were classified by the World Bank as ‘‘high
income countries’’ were combined in one group called affluent
countries. The remaining centres were combined as nonaffluent countries (GNI ,US$9,200 per capita in 2001).
Outcome
The question ‘‘Has your child had wheezing or whistling in the
chest in the past 12 months?’’ was used as the indicator for
childhood asthma. In addition, the lifetime prevalence of
asthma was investigated using the question ‘‘Has your child
ever had asthma?’’ SPTs were performed on 31,759 children
using six common aeroallergens: Dermatophagoides pteronyssinus,
Dermatophagoides farinae, cat hair, Alternaria tenuis and mixed
tree and grass pollen (ALK-Albelló, Hørsholm, Denmark). In
addition, data on locally relevant allergens tested in 15 centres
were included. For this analysis at least one positive reaction
(wheal size o3 mm after subtraction of the negative control)
was defined as a positive SPT. Atopic wheeze was defined as
wheeze during the past year and a positive SPT [18].
Spirometry was performed according to the American
Thoracic Society criteria [19]. At least two spirograms were
recorded, and the higher of two reproducible measurements
(with ,5% variation) of forced expiratory volume in one
second (FEV1) was recorded as baseline value. Values of FEV1
% predicted were used as a descriptor of lung function and
were calculated based on age, weight (except Albania and the
UK) and height stratified for sex and centre by linear
regression models. High FEV1 % pred indicates good lung
function.
As described elsewhere in detail [15] BHR was assessed using a
DeVilbiss nebuliser (Sunrise Medical, Malsch, Germany) by
further measurements of FEV1 after inhalation of nebulised
hyperosmolar saline (4.5%) for increasing time periods (0.5, 1, 2,
4 and 8 min) [20]. FEV1 was measured 1 min after the end of
each inhalation period and the next challenge was performed
after 3 min wash-out time. If FEV1 fell 10–15% below the
baseline value, the previous exposure time was repeated. If after
two repetitions the fall of FEV1 was still between 10% and 15%,
the exposure time was also doubled. Bronchial challenge was
stopped if either the FEV1 had fallen by o15% or the total
inhalation period of 15.5 min had been reached. In children with
a baseline FEV1 of ,75% pred, no bronchial challenge was
performed and an inhaled bronchodilator was administered.
Statistical analysis
For stratified subsamples, weighted prevalences and risk
estimates were calculated [21]. Random effect models for
EUROPEAN RESPIRATORY JOURNAL
G. NAGEL ET AL.
meta-analysis were applied to calculate crude and adjusted
odds ratios (ORs) or mean ratios (MRs) for FEV1 % pred with
95% confidence intervals (CI) combined for affluent and
nonaffluent countries [22]. The following potential confounders were considered: sex and age of the child, in order to
control for age or sex differences; exposure to ETS at present,
to control for respiratory symptoms due to tobacco smoke;
present bedroom sharing with other persons, used to control
for family size and living conditions; and maternal atopic
disease, to control for an increased risk of atopy and
potential lifestyle modifications. Heterogeneity between
centres was estimated from random effect meta-analysis
was tested with the Wald statistics (p-value). In case of
heterogeneity, fixed random effect models were calculated
and a statistical test on differences of the study means based
on the Chi-squared distribution was performed (Pfixed).
Interaction was investigated by including a product term in
the logistic regression equation.
Depending on the prevalence and completeness of the
variables, the number of subjects and sometimes the number
of centres/countries in the models differed if some subjects/
centres did not contribute any information and, therefore, had
to be excluded.
All calculations were performed and stratified by each centre
and the combined estimates for affluent and nonaffluent
countries are shown. Further stratification by maternal atopic
disease, sex and atopic and nonatopic wheeze was performed.
RESULTS
Table 1 shows the basic characteristics of the study populations. The prevalence of any breastfeeding ranged between
26.4% in Hong Kong (China) to 100% in Pichincha (Ecuador).
The proportion of children reporting wheeze during the past
year ranged from 0.8% in Pichincha (Ecuador) to 25.6% in
Uruguaiana (Brazil). The lifetime prevalence of asthma ranged
between 2.7% in Tirana (Albania) to 35.6% in Hawkes Bay
(New Zealand). Among breastfed children, mothers with
atopic disease and bedroom sharing were more prevalent than
among nonbreastfed children.
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
similar trend was noted in nonaffluent countries (ORadj 0.89,
95% CI 0.71–1.11; table 3).
Breastfeeding showed no significant relationship with atopic
wheeze for either affluent (ORadj 0.85, 95% CI 0.67–1.08;
p50.13) or nonaffluent countries (ORadj 0.86, 95% CI 0.55–1.35;
p50.27; table 4). For nonatopic wheeze, the inverse association
with breastfeeding was stronger in nonaffluent countries
(ORadj 0.69, 95% CI 0.53–0.90; Pfixed 0.98) than affluent
countries (ORadj 0.87, 95% CI 0.72–1.06; p50.48). Moreover,
no associations were found between breastfeeding practice and
positive SPT or elevated specific IgE levels, either in affluent or
nonaffluent countries (see online supplementary material).
The associations between any breastfeeding and wheeze were
not affected by maternal atopy in affluent (ORadj 0.93, 95% CI
0.79–1.10, p50.50 and ORadj 0.82, 95% CI 0.71–0.95, p50.50,
respectively), or in nonaffluent countries (ORadj 0.78, 95% CI
0.48–1.27, p50.23 and ORadj 0.80, 95% CI 0.66–0.96, p50.50,
respectively). In affluent countries, the inverse association
between breastfeeding and wheeze was more pronounced for
females (ORadj 0.78, 95% CI 0.64–0.95; Pfixed 0.69) than for
males (ORadj 0.95, 95% CI 0.83–1.10; Pfixed 0.91), while the
opposite was true in nonaffluent countries (ORadj 0.73, 95% CI
0.56–0.95, p50.33 in males versus ORadj 0.82, 95% CI 0.64–1.05,
p50.49 in females). When all countries were combined, there
was no significant effect modification by sex (p50.455).
Breastfeeding tended to be inversely related to BHR in affluent
and nonaffluent countries, but none of the associations were
statistically significant (ORadj 0.92, 95% CI 0.75–1.12; p50.50
and ORadj 0.66, 95% CI 0.37–1.20, p50.50, respectively; fig. 1a).
However, breastfed children tended to have better lung
function as determined by FEV1 % in affluent countries (MR
1.11, 95% CI 1.02–1.20; p50.42), but not in nonaffluent
countries (MR 0.89, 95% CI 0.68–1.17; p50.30; fig. 1b). This
interaction with affluence was not significant (p50.564).
Table 2 shows the crude and adjusted associations between
breastfeeding and wheeze during the past year. In the
multivariate models, breastfeeding was inversely associated
with wheeze during the past year, both in affluent countries
(adjusted OR (ORadj) 0.87, 95% CI 0.78–0.97; p50.50) and in
nonaffluent countries (ORadj 0.80, 95% CI 0.68–0.94; p50.50).
Although going in the expected direction, no significant effect
was found for the duration of breastfeeding in affluent
countries, whereas in nonaffluent countries breastfeeding for
o6 months was associated with less wheeze (ORadj 0.74, 95% CI
0.62–0.88; p50.25). In affluent countries, the duration of
exclusive breastfeeding tended to be inversely associated with
wheeze, but reached statistical significance only for the category
2–4 months. However, in nonaffluent countries exclusive
breastfeeding for o2 months (ORadj 0.77, 95% CI 0.63–0.94;
p50.17) and .4 months (ORadj 0.74, 95% CI 0.61–0.90; p50.47)
was inversely associated with wheeze. In addition, any
breastfeeding was related to a reduced lifetime prevalence of
asthma in affluent countries (ORadj 0.87, 95% CI 0.78–0.97) and a
DISCUSSION
In line with some of the previous literature [6, 7, 11–14, 23], but
in contrast to some other reports [9, 10, 24], the present authors
observed an inverse association between breastfeeding and
wheezing. This was particularly true in nonaffluent countries.
Breastfeeding for o6 months, and .2 months of exclusive
breastfeeding, were associated with less wheeze in nonaffluent
countries, while there was no consistent evidence that the
duration of breastfeeding was associated with asthma in
affluent countries. Furthermore, the protective effect of
breastfeeding against childhood wheezing was limited to
nonatopic wheeze, while IgE-associated wheeze and atopic
sensitisation were not affected. The current findings could
explain at least some of the current controversy regarding the
relationship between breastfeeding and wheezing later in
childhood. While overall there was a protective effect of
breastfeeding against wheeze, in reality it was evident only for
nonatopic wheeze in nonaffluent countries. In affluent countries, where wheezing is more commonly associated with
allergy, breastfeeding showed no relationship with wheeze,
despite the large sample size. Depending on the predominant
wheeze phenotype in populations, an association between
breastfeeding and wheeze may appear.
EUROPEAN RESPIRATORY JOURNAL
VOLUME 33 NUMBER 5
995
c
Sample characteristics and the prevalence of wheeze and lifetime asthma in children aged 8–12 yrs in the ISAAC phase two centres
Centre
Study
Prevalence
sample wheeze past
Lifetime
Breastfed Breastfeeding
prevalence
12 months
of asthma
5.5
7.9
.6 months
Shared
Maternal
ETS at
breastfeeding
Exclusive
Age yrs
bedroom at
atopy
present
Positive IgE .0.35
SPT
.4 months
present
BHR
FEV1 %
kU?L-1
reactivity
pred
Affluent
countries#
China
Germany
Greece
Hong Kong
3011
792 (26.4)
13.5
9.9
10.2¡0.5
89.3
6.5
33.6
45.3+
Dresden
3032
7.9
3.6
2500 (85.6)
26.6
12.2
9.7¡0.6
50.5
26.9
32.7
25.7
37.0
10.5
101.6
Munich
3301
8.3
4.8
2445 (79.5)
34.6
21.4
9.5¡0.6
67.8
27.0
42.2
22.3
37.4
17.9
102.1
Athens
985
5.6
7.5
769 (78.7)
23.0
16.4
9.8¡0.4
65.0
28.1
58.5
14.4+
33.61
13.61
99.61
+
1
1
39.9
101.31
Thessaloniki
1018
8.4
11.6
747 (74.6)
20.0
12.2
9.7¡0.5
72.1
23.9
55.7
e
26.8
32.3
VOLUME 33 NUMBER 5
Iceland
Reykjavik
937
9.2
22.9
884 (96.5)
62.5
37.1
10.4¡0.5
21.3
35.0
30.0
23.5
Italy
Rome
1354
7.9
14.3
1022 (76.4)
32.8
30.3
10.0¡0.4
63.2
27.9
49.1
28.9+
43.11
33.11
100.21
Netherlands
Utrecht
9.5¡1.2
85.4
52.6
56.3
30.9+
30.1
19.8
98.9
55.8
33.0
10.9¡0.5
35.6
49.1
27.9
34.5
23.9
95.0
New Zealand Hawkes Bay
Norway
Spain
Tromsø
Almeria
Cartagena
Madrid
Valencia
UK
3541
8.7
7.8
2343 (66.7)
1320
21.9
35.6
1138 (86.9)
3669
1126
1129
981
1362
14.0
15.5
11.9
11.6
9.1
10.3
14.6
10.9
11.4
9.8
3457 (94.9)
799 (71.7)
1004 (71.7)
760 (77.9)
905 (67.1)
66.6
20.4
22.8
27.7
18.8
35.8
18.1
18.3
25.5
14.7
9.9¡0.7
10.2¡0.6
9.5¡0.6
9.4¡0.7
9.5¡0.5
25.7
100.0
41.5
52.4
31.4
38.4
29.1
28.2
29.6
28.0
37.6
60.4
58.0
57.0
56.3
32.7
43.0
+
23.8
+
34.5
+
14.3
+
36.5
1
1
48.5
1
105.01
1
40.4
1
105.61
1
23.7
40.1
1
1
90.41
32.9
1
1
42.7
29.7
8.9
102.11
1
94.21
1
41.4
96.11
24.4
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
996
TABLE 1
West Sussex
1056
16.2
20.3
628 (77.0)
40.0
11.7
10.4¡1.3
25.3
34.5
29.0
17.5
41.8
Tirana
1052
4.4
2.7
915 (92.4)
69.4
47.6
9.9¡0.6
73.1
9.0
47.7
14.7+
19.51
2.11
99.21
30.61
29.51
90.11
30.4
94.5
39.71
47.81
83.11
13.5
107.9
Nonaffluent
countries"
Albania
Uruguaiana
1971
25.6
12.7
1694 (86.5)
54.0
35.3
9.6¡0.8
80.8
20.6
51.5
13.3
Beijing
4214
3.7
6.4
2013(48.7)
30.8
15.1
10.4¡0.5
89.8
7.4
62.3
23.9+
Guangzhou
3510
3.2
4.4
2638 (75.2)
56.8
30.2
9.8¡0.5
79.8
4.8
54.8
32.0+
Ecuador
Pichincha
894
0.8
894 (100)
91.7
10.0¡1.6
90.2
5.8
47.1
19.7+
Georgia
Tbilisi
1012
9.2
3.2
718 (72.7)
31.1
22.3
10.4¡0.6
82.2
27.5
58.7
33.0+
Ghana
Kintampo
1354
6.4
15.8
1325 (97.9)
99.4
72.7
10.3¡0.6
100
34.6
22.3
1.7
India
Mumbai
1658
6.1
4.8
1607 (97.6)
87.9
84.9
9.9¡0.8
87.5
1.9
19.8
6.4
Latvia
Riga
908
6.9
3.2
813 (90.2)
38.0
14.3
10.7¡0.6
58.1
10.5
39.2
19.3
West Bank
Ramallah
2304
8.8
9.4
268 (91.7)1
74.8
52.6
9.8¡0.8
91.41
19.21
64.2
10.31
63.1
+
Turkey
Ankara
2976
10.9
NA
2758 (94.2)
64.8
51.2
9.1¡0.5
70.8
34.9
24.6
80.1
22.4
105.71
Data are presented as n, %, n (%) or mean¡ SD, unless otherwise stated. ISAAC: the International Study on Allergies and Asthma in Childhood study; ETS: environmental tobacco smoke; SPT: skin prick test;
Ig: immunoglobulin; BHR: bronchial hyperreactivity; FEV1: forced expiratory volume in one second; % pred: % predicted. #: gross national income (GNI) oUS$9,200 per capita in 16 centres with 29,222 children; ": GNI
,US$9,200 per capita in 11 centres with 21,851 children; +: local allergens were tested in addition to the standard set of six common allergens 1: stratified subsamples; e: average age of 10.4 yrs was used due to strict data
protection rules.
G. NAGEL ET AL.
EUROPEAN RESPIRATORY JOURNAL
Brazil
China
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
G. NAGEL ET AL.
TABLE 2
Association between breastfeeding practice and wheeze in the previous year by affluence#
Affluent countries"
Nonaffluent countries+
Adjusted1
Crude
OR
95% CI
OR
95% CI
No
1
Yes
0.89
Reference
1
0.81–0.99
0.87
Adjusted1
Crude
OR
95% CI
OR
95% CI
Reference
1
0.78–0.97
0.81
Reference
1
Reference
0.70–0.95
0.80
0.68–0.94
Breastfeedinge
Duration of breastfeeding
##
Not breastfed
1
Reference
1
Reference
1
Reference
1
Reference
,6 months
0.91
0.8–1.03
0.88
0.78–1.00
0.94
0.76–1.16
0.95
0.73–1.23
o6 months
0.89
0.77–1.04
0.88
0.76–1.03
0.75
0.63–0.89
0.74
0.62–0.88
1
Reference
1
Reference
1
Reference
1
Reference
""
Exclusive breastfeeding
Not breastfed
2 months
0.94
0.80–1.09
0.91
0.78–1.06
1.00
0.75–1.33
0.98
0.70–1.37
2–4 months
0.88
0.78–1.01
0.85
0.74–0.98
0.80
0.67–0.97
0.77
0.63–0.94
o4 months
0.93
0.80–1.08
0.92
0.78–1.10
0.74
0.61–0.89
0.74
0.61–0.90
OR: odds ratio; CI: confidence interval. #: random effect models for meta-analysis; ": gross national income (GNI) oUS$9,200 per capita in 16 centres with 29,222
children; +: GNI ,US$9,200 per capita in 11 centres with 21,851 children; 1: adjusted for sex, age, maternal atopic disease, environmental tobacco smoke and present
bedroom sharing; e: without Pichincha (Ecuador), for affluent countries 2,807 out of 28,058 and nonafluent countries 1,514 out of 18,581;
Netherlands) and Kintampo (Ghana), for affluent countries 2,445 out of 23,716 and nonaffluent countries 1,423 out of 17,841;
##
: without Utrecht (the
""
: without Utrecht (the Netherlands),
Kintampo (Ghana) and Pichincha (Ecuador), for affluent countries 2,352 out of 22,525 and nonaffluent countries 1,392 out of 16,223.
TABLE 3
Associations between breastfeeding practice and lifetime prevalence of asthma# by affluence"
Nonaffluent countries1
Affluent countries+
Adjustede
Crude
OR
95% CI
No
1
Reference
Yes
0.87
0.78–0.96
OR
Adjustede
Crude
95% CI
OR
95% CI
OR
95% CI
Reference
1
Reference
1
Reference
0.87
0.78–0.97
0.93
0.79–1.10
0.89
0.71–1.11
Breastfeeding##
Duration of breastfeeding""
Not breastfed
1
Reference
1
Reference
1
Reference
1
Reference
,6 months
0.89
0.77–1.03
0.90
0.77–1.04
1.12
0.90–1,39
1.09
0.86–1.39
o6 months
0.84
0.72–0.97
0.87
0.75–1.00
0.85
0,71–1.03
0.83
0.67–1.03
Reference
++
Exclusive breastfeeding
Not breastfed
1
Reference
1
Reference
1
Reference
1
2 months
0.91
0.79–1.05
0.92
0.79–1.06
1.20
0.96–1.50
1.14
0.91–1.44
2–4 months
0.87
0.76–0.99
0.88
0.77–1.01
0.92
0.68–1.23
0.86
0.63–1.17
o4 months
0.87
0.75–1.02
0.91
0.78–1.07
0.74
0.59–0.92
0.75
0.60–0.94
OR: odds ratio; CI: confidence interval. #: defined by parental report on asthma diagnosis; ": random effect models for meta-analysis; +: gross national income (GNI)
oUS$9,200 per capita in 16 centres with 29,222 children; 1: GNI ,US$9,200 per capita in 11 centres with 21,851 children; e: adjusted for sex, age, maternal atopic
disease, environmental tobacco smoke and present bedroom sharing;
countries 1,192 out of 15,593;
""
##
: without Pichincha (Ecuador), for affluent countries 2,723 out of 27,550 and nonaffluent
: without Utrecht (the Netherlands), Pichincha (Ecuador), Ankara (Turkey) and Kintampo (Ghana), for affluent countries 2,369 out of
23,250 and nonaffluent countries 1,100 out of 14,047; ++: without Utrecht (the Netherlands), Pichincha (Ecuador) and Ankara (Turkey), for affluent countries 2,279 out of
22,091 and nonaffluent countries 1,154 out of 14,514.
EUROPEAN RESPIRATORY JOURNAL
VOLUME 33 NUMBER 5
997
c
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
TABLE 4
G. NAGEL ET AL.
Association of breastfeeding practice with atopic and nonatopic wheeze# during the previous year by affluence"
Nonaffluent countries1
Affluent countries+
Adjustede
Crude
OR
95% CI
No
1
Yes
0.87
Adjustede
Crude
OR
95% CI
OR
95% CI
Reference
1
0.68–1.11
0.85
OR
95% CI
Reference
1
0.67–1.08
0.84
Reference
1
Reference
0.57–1.25
0.85
0.54–1.34
Reference
Atopic wheeze
Breastfeeding##
Duration of breastfeeding""
Not breastfed
1
Reference
1
Reference
1
Reference
1
,6 months
0.90
0.70–1.16
0.89
0.70–1.13
1.02
0.81–1.30
1.01
0.64–1.57
o6 months
0.88
0.68–1.13
0.87
0.68–1.11
0.78
0.50–1.23
0.78
0.46–1.33
Exclusive breastfeeding++
Not breastfed
1
Reference
1
Reference
1
Reference
1
Reference
2 months
0.93
0.66–1.31
0.92
0.65–1.29
1.01
0.94–1.09
1.08
0.74–1.58
2–4 months
0.88
0.71–1.08
0.85
0.69–1.05
1.00
0.94–1.06
0.92
0.68–1.24
o4 months
0.90
0.68–1.21
0.92
0.69–1.24
0.66
0.44–0.98
0.68
0.44–1.05
No
1
Reference
1
Reference
1
Reference
1
Reference
Yes
0.88
0.73–1.05
0.87
0.72–1.06
0.71
0.55–0.92
0.69
0.53–0.90
Reference
Nonatopic wheeze
Breastfeeding11
Duration of breastfeedingee
Not breastfed
1
Reference
1
Reference
1
Reference
1
,6 months
0.87
0.71–1.07
0.88
0.69–1.11
0.32
0.03–3.23
0.82
0.61–1.11
o6 months
0.98
0.78–1.22
1.00
0.79–1.26
0.68
0.52–0.89
0.64
0.49–0.85
Exclusive breastfeeding###
Not breastfed
1
Reference
1
Reference
1
Reference
1
Reference
2 months
0.92
0.72–1.17
0.93
0.71–1.21
0.77
0.56–1.06
0.72
0.51–1.02
2–4 months
0.91
0.74–1.13
0.90
0.72–1.13
0.71
0.53–0.95
0.68
0.50–0.90
o4 months
0.96
0.72–1.27
0.98
0.73–1.31
0.73
0.55–0.98
0.75
0.55–1.00
OR: odds ratio; CI: confidence interval. #: defined as wheeze with (atopic) and without (nonatopic) skin prick test positivity; ": random effect models for meta-analysis;
+
: gross national income (GNI) oUS$9,200 per capita in 16 centres with 29,222 children; 1: GNI ,US$9,200 per capita in 11 centres with 21,851 children; e: adjusted for
sex, age, maternal atopic disease, environmental tobacco smoke and present bedroom sharing;
##
: without Pichincha (Ecuador), for affluent countries 1,676 out of
15,610 and nonaffluent countries 907 out of 8,503; "": without Utrecht (the Netherlands), Pichincha (Ecuador), Kintampo (Ghana) and Ramallah (West Bank), for affluent
countries 1,514 out of 13,646 and nonaffluent countries 805 out of 6,882; ++: without Utrecht (The Netherlands) and Pichincha (Ecuador), for affluent countries 1,532 out of
13,894 and nonaffluent countries 906 out of 7,952; 11: without Reykjavik (Iceland) and Pichincha (Ecuador), for affluent countries 1,676 out of 15,610 and for nonaffluent
countries 1,004 out of 9,741;
ee
: for affluent countries 1,606 out of 14,580 and nonaffluent countries 1,027 out of 10,723;
###
: without Reykjavik (Iceland), Utrecht (the
Netherlands), Pichincha (Ecuador) and Kintampo (Ghana), for affluent countries 1,429 out of 12,776 and nonaffluent countries 818 out of 7,173.
Other authors found breastfeeding for o4 months to be
associated with less wheeze, compared with children who
were never breastfed [12, 25]. Results from a recent randomised intervention study on prolonged and exclusive breastfeeding revealed no protective effect on symptoms of allergies,
asthma and SPT positivity among 6.5-yr-old children in
Belarus [5]. The present results indicate no major reduction
in the prevalence of prolonged breastfeeding or exclusive
breastfeeding for .4 months in affluent countries in contrast to
nonaffluent countries where the prevalence of wheeze was
lower. There is evidence for age-dependent prevalence and
phenotype patterns in children [26]. Different prevalences of
the wheeze phenotypes nonatopic and atopic (IgE-associated)
wheeze may explain the differential associations by affluence
status. The present authors found favourable FEV1 % values
among breastfed children in affluent countries. Again,
998
VOLUME 33 NUMBER 5
differences in the prevalence of nonatopic and atopic (IgEassociated) wheeze may explain the differential associations by
affluence status.
The reviews by VAN ODIJK et al. [6] and GDALEVICH et al. [7]
reported an overall protective effect of breastfeeding on
asthma prevalence, especially in children with a family history
of atopy. The current study, comprising 54,000 children in 20
countries, could not confirm this, as a slightly stronger inverse
association with breastfeeding in children without maternal
atopy in affluent but not in nonaffluent countries was
observed.
There is more or less a consensus that breastfeeding offers
protection against infections and thus also against wheezing in
infancy [1, 2]. Prospective studies have revealed that recurrent
respiratory infections in infancy may indicate a predisposition
EUROPEAN RESPIRATORY JOURNAL
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
G. NAGEL ET AL.
a) Cartagena
Almeria
Madrid
Valencia
Dresden
Munich
Athens
Thessaloniki
Rome
Utrecht
Tromsø
West Sussex
Hawkes Bay
Combined
affluent#
Tirana
Ankara
Mumbai
Tbilisi
Riga
Combined
nonaffluent¶
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
1
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
◆
Tirana
Ankara
Kintampo
Mumbai
Tbilisi
Ramallah
Riga
Combined
nonaffluent§
◆
0
FIGURE 1.
b) Cartagena
Almeria
Madrid
Valencia
Dresden
Munich
Athens
Thessaloniki
Rome
Utrecht
Tromsø
West Sussex
Hawkes Bay
Combined
affluent+
◆
2
3
4
5
6
7
8
◆
◆
◆
◆
◆
◆
◆
◆
◆
0
1
2
3
4
5
Meta-analysis random effect models for associations between a) breastfeeding and bronchial hyperreactivity (odds ratio (OR) and 95% confidence interval
(CI)) and b) breastfeeding and predicted forced expiratory volume in one second (means ratio (MR) and 95% CI), adjusted for sex, age, maternal atopic disease,
environmental tobacco smoke and present bedroom sharing. #: gross national income (GNI) oUS$9,200 per capita in 13 centres with 4,028 children; ": GNI ,US$9,200 per
capita in five centres with 860 children; +: GNI oUS$9,200 per capita in 13 centres with 6,348 children; 1: GNI ,US$9,200 per capita in seven centres with 1,376 children.
¤: OR or MR for each country; e: total OR or MR for affluent and nonaffluent countries; –––: confidence intervals.
for wheezing and BHR [27, 28]. WRIGHT et al. [24] found that
breastfeeding has a protective effect early in life, whereas it
may be associated with an increased risk of asthma in
adolescents, especially in atopic children of asthmatic mothers.
Results of a cohort study from Australia suggest that the
association between breastfeeding and asthma may depend on
the age of manifestation, conferring protection up to the age of
7 yrs, but associated with an increased risk for asthma after
this age [29]. As asthma is usually not associated with allergy
during the first years of life, in contrast to the situation in older
children, these findings would support the current observations that breastfeeding was associated with less wheezing but
not less sensitisation and particularly so in nonaffluent
countries.
effect of breastfeeding is also supported by the observations
that the thymus size was larger in breastfed than in nonbreastfed
infants [32]. The effect of breastfeeding may depend on the age of
asthma onset, with a stronger protective effect for early asthma
onset [12, 29]. In the present study, breastfeeding had favourable
effects on wheeze during the previous year and particularly on
nonatopic wheeze in nonaffluent countries, suggesting an
infection-linked immune modulation. It is also possible that the
composition of breast milk was affected by socioeconomic
factors, maternal diet, pollutants, and the nature of microbiological exposure [3, 31].
Breastfeeding may influence the immunological and respiratory
function during early childhood [2]. A long-term immunological
After stratification by sex the protective effect of breastfeeding
remained stronger in females than in males in affluent
countries, whereas the opposite was found in nonaffluent
countries. This observation is in agreement with another report
concerning neonatal respiratory infections [33]. Other environmental factors, such as diet, infections or hormones, may
further contribute to sex-specific patterns of associations
between breastfeeding, asthma and allergies [34]. However,
in the current study, breastfeeding was unrelated to either of
the primary risks/cofactors of asthma (atopy and BHR), which
supports the lack of relationship with atopic wheeze. In
affluent societies, the protective effect of breastfeeding against
nonatopic wheeze, which is probably mainly due to infections,
is marginal, while it is a major factor in developing countries.
This observation is corroborated by the findings that substantially higher fractions of current wheeze are attributable to SPT
reactivity in affluent compared with nonaffluent countries [18].
In addition, lower prevalence rates of SPT reactivity were
found in less affluent countries [18].
EUROPEAN RESPIRATORY JOURNAL
VOLUME 33 NUMBER 5
Human milk contains various bioactive and immunomodulatory constituents, such as antibodies, oligosaccharides, cells and
cytokines [3, 30]. The composition of breast milk differs between
allergic and nonallergic mothers and it has been suggested that
this could explain some of the controversy regarding the
possible allergy-preventive effects of breastfeeding [30]. In
support of this, a Swedish study has shown that the composition
of PUFA in breast milk not only differed between allergic and
nonallergic mothers but also affected the development of
allergic disease, at least up to the age of 2 yrs [31]. Such
differences could also explain the observations by WRIGHT et al.
[24] that children who were breastfed by allergic compared with
nonallergic mothers had a higher incidence of allergies.
999
c
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
Some limitations have to be kept in mind. Since a crosssectional study was performed and the data on breastfeeding
history were collected retrospectively, recall biases are likely,
which may have affected more the duration and exclusiveness
of breastfeeding than breastfeeding per se. In addition, no
detailed information on early infections was available. Parental
socioeconomic conditions varied within the centres and may
have confounded observations. However, the calculation of
models adjusting for years of maternal or paternal education as
an indicator for socioeconomic position for the centres with
available information did not substantially affect the associations. Multiple comparisons were performed, which need to be
considered for the interpretation of the results. The application
of well established and standardised questionnaires and
methodology in the centres would support the consistency of
the findings across centres in affluent and nonaffluent
countries. In addition, objective markers of allergy sensitisation
and lung function were applied. The current study added
results from nonaffluent countries.
The present results provide evidence that breastfeeding is
protective against nonallergic wheeze among children aged
8–12 yrs in nonaffluent societies. However, there was no
protective relationship of breastfeeding with measures of
allergy. These findings may explain some of the controversy
regarding the long-term effects of breastfeeding on respiratory
symptoms, as atopic (immunoglobulin E-associated) and
nonatopic wheeze were clearly not separated in most previous
studies. Depending on which type of wheeze phenotype
predominates (e.g. atopic or nonatopic) at a particular age,
breastfeeding may exert a protective or marginal effect on
wheeze. Further research needs to consider differential pathways according to atopic and nonatopic wheeze phenotype.
ACKNOWLEDGEMENTS
The affiliations of the present authors are as follows. G. Nagel,
G. Büchele, G. Weinmayr and S.K. Weiland: Institute of
Epidemiology, Ulm University, Ulm, Germany. B. Björkstén:
Institute of Environmental Medicine, Karolinska Institutet
Stockholm, Stockholm, Sweden. Y-Z. Chen: Capital Institute of
Paediatrics, Beijing, People’s Republic of China. H. Wang:
Guangzhou Institute of Respiratory Diseases, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou,
People’s Republic of China, and Firestone Institute for
Respiratory Health, St Joseph’s Healthcare, and Dept of
Medicine, McMaster University, Hamilton, ON, Canada.
W. Nystad: Norwegian Institute of Public Health, Division of
Epidemiology, Tromsø, Norway. Y. Saraclar: Dept of Paediatric
Allergy and Asthma, Hacettepe University, Ankara, Turkey.
L. Bråbäck: Dept of Public Health and Research, Sundsvall
Hospital, Sundsvall, Sweden. J. Batles-Garrido: Paediatric Dept,
Torrecárdenas Hospital, Almeria, Spain. G. Garcia-Hernandez:
Paediatric Allergy and Pulmonology Unit, Doce de Octubre
University Children’s Hospital, Madrid, Spain.
The ISAAC II Steering Group consists of the following.
B. Björkstén (Stockholm, Sweden), B. Brunekreef (Utrecht, the
Netherlands), W. Cookson (Oxford, UK), D. Strachan (London,
UK), E. von Mutius (Munich, Germany), and S.K. Weiland{
(ISAAC II Coordinator; Ulm, Germany).
1000
VOLUME 33 NUMBER 5
G. NAGEL ET AL.
The present authors wish to thank all children, parents,
teachers, field workers and laboratory workers for their
enormous contributions to this collaborative study and
A. Kleiner (Ulm, Germany) for her excellent technical assistance.
S.K. Weiland, head of the Institute of Epidemiology, Ulm
University (Ulm, Germany), died suddenly and unexpectedly
on March 19, 2007. The present authors will always remember
him as a generous and supportive mentor and as a great scientist
with a genuine enthusiasm for international collaboration.
The ISAAC II Coordinating and Data Centre consists of
the following. G Büchele, A. Kleiner, G. Nagel, P. Rzehak,
G. Weinmayr and S.K. Weiland{ (Director; all Institute of
Epidemiology, Ulm University, Germany).
The following are Principal Investigators and members of
the Scientific Team. A. Priftanji, A. Shkurti, J. Simenati,
E. Grabocka, K. Shyti, S. Agolli and A. Gurakuqi (Tirana,
Albania); R.T. Stein, M. Urrutia de Pereira, M.H. Jones and
P.M. Pitrez (Uruguaiana, Brazil); P.J. Cooper and M. Chico
(Pichincha province, Ecuador); Y.Z. Chen (Bejing), N.S. Zhong
(Guangzhou) and C. Lei (National Coordinator; Hong Kong,
all China); G. Wong, M-A. Riikjärv and T. Annus (Tallinn,
Estonia); I. Annesi-Maesano (Créteil, France); M. Gotua,
M. Rukhadze, T. Abramidze, I. Kvachadze, L. Karsanidze,
M. Kiladze and N. Dolidze (Tblisi, Georgia); W. Leupold,
U. Keil, E von Mutius and S.K. Weiland{ (Dresden, Germany);
E. von Mutius, U. Keil and S.K. Weiland{ (Munich, Germany);
P. Arthur{ and E. Addo-Yobo (Kintampo, Ghana); C. Gratziou
(National Coordinator), C. Priftis, A. Papadopoulou and
C. Katsardis (Athens, Greece); J. Tsanakas, E. Hatziagorou,
F. Kirvassilis (Thessaloniki, Greece); M. Clausen (Reykjavik,
Iceland); J.R. Shah, R.S. Mathur, R.P. Khubchandani and
S. Mantri (Mumbai, India); F. Forastiere, R. Di Domenicantonio, M. De Sario, S. Sammarro, R. Pistelli, M.G. Serra,
G. Corbo and C.A. Perucci (Rome, Italy); V. Svabe, D. Sebre,
G. Casno, I. Novikova and L. Bagrade (Riga, Latvia);
B. Brunekreef, D. Schram, G. Doekes, P.H.N. Jansen-van
Vliet, N.A.H. Janssen, F.J.H. Aarts and G. de Meer (Utrecht,
the Netherlands); J. Crane, K. Wickens and D. Barry (Hawkes
Bay, New Zealand); W. Nystad, R. Bolle and E. Lund (Tromsø,
Norway); N. El-Sharif, B. Nemery, F. Barghuthy, S. Abu Huij
and M. Qlebo (Ramallah, West Bank); J. Batlles Garrido,
T. Rubi Ruiz, A. Bonillo Perales, Y. Gonzalez Jiménez,
J. Aguirre Rodriguez, J. Momblan de Cabo, A. Losilla
Maldonado and M. Daza Torres (Almeria, Spain); L. GarciaMarcos (National Coordinator), A. Martinez Torres, J.J. Guillén
Pérez, A. Piñana López and S. Castejon Robles (Cartagena,
Spain); G. Garcia Hernandez, A. Martinez Gimeno, A.L. Moro
Rodrı́guez, C. Luna Paredes and I. Gonzalez Gil (Madrid,
Spain); M.M. Morales Suarez-Varela, A. Llopis González,
A. Escribano Montaner and M. Tallon Guerola (Valencia, Spain);
L. Bråbäck (National Coordinator), M. Kjellman, L. Nilsson and
X-M. Mai (Linköping, Sweden); L. Bråbäck and A. Sandin
(Östersund, Sweden); Y. Saraçlar, S. Kuyucu, A. Tuncer,
C. Saçkesen, V. Sumbuloğlu, P. Geyik and C. Kocabaş (Ankara,
Turkey); D. Strachan and B. Kaur (West Sussex, UK).
The ISAAC Steering Committee includes the following. N. Aı̈tKhaled (Paris, France); H.R. Anderson and D.P. Strachan
EUROPEAN RESPIRATORY JOURNAL
G. NAGEL ET AL.
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
REFERENCES
1 Howie PW, Forsyth JS, Ogston SA, Clark A, Florey CD.
Protective effect of breast feeding against infection. BMJ
1990; 300: 11–16.
2 Wills-Karp M, Brandt D, Morrow AL. Understanding the
origin of asthma and its relationship to breastfeeding. Adv
Exp Med Biol 2004; 554: 171–191.
3 Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev
Immunol 2004; 4: 565–572.
4 Friedman NJ, Zeiger RS. The role of breast-feeding in the
development of allergies and asthma. J Allergy Clin
Immunol 2005; 115: 1238–1248.
5 Kramer MS, Matush L, Vanilovich I, et al. Effect of
prolonged and exclusive breast feeding on risk of allergy
and asthma: cluster randomised trial. BMJ 2007; 335: 815.
6 van Odijk J, Kull I, Borres MP, et al. Breastfeeding and
allergic disease: a multidisciplinary review of the literature
(1966–2001) on the mode of early feeding in infancy and its
impact on later atopic manifestations. Allergy 2003; 58:
833–843.
7 Gdalevich M, Mimouni D, David M, Mimouni M. Breastfeeding and the onset of atopic dermatitis in childhood: a
systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001; 45: 520–527.
8 Rusconi F, Galassi C, Corbo GM, et al. Risk factors for
early, persistent, and late-onset wheezing in young
children. SIDRIA Collaborative Group. Am J Respir Crit
Care Med 1999; 160: 1617–1622.
9 Sears MR, Greene JM, Willan AR, et al. Long-term relation
between breastfeeding and development of atopy and
asthma in children and young adults: a longitudinal study.
Lancet 2002; 360: 901–907.
10 Bergmann RL, Diepgen TL, Kuss O, et al. Breastfeeding
duration is a risk factor for atopic eczema. Clin Exp Allergy
2002; 32: 205–209.
11 Kramer MS, Chalmers B, Hodnett ED, et al. Promotion of
Breastfeeding Intervention Trial (PROBIT): a randomized
trial in the Republic of Belarus. JAMA 2001; 285: 413–420.
12 Kull I, Almqvist C, Lilja G, Pershagen G, Wickman M.
Breast-feeding reduces the risk of asthma during the first 4
years of life. J Allergy Clin Immunol 2004; 114: 755–760.
13 Oddy WH, Peat JK, de Klerk NH. Maternal asthma, infant
feeding, and the risk of asthma in childhood. J Allergy Clin
Immunol 2002; 110: 65–67.
14 Laubereau B, Brockow I, Zirngibl A, et al. Effect of breastfeeding on the development of atopic dermatitis during the
first 3 years of life – results from the GINI-birth cohort
study. J Pediatr 2004; 144: 602–607.
15 Weiland SK, Bjorksten B, Brunekreef B, Cookson WO,
von Mutius E, Strachan DP. Phase II of the International Study of Asthma and Allergies in Childhood
(ISAAC II): rationale and methods. Eur Respir J 2004; 24:
406–412.
16 Asher MI, Keil U, Anderson HR, et al. International Study
of Asthma and Allergies in Childhood (ISAAC): rationale
and methods. Eur Respir J 1995; 8: 483–491.
17 The World Bank Group. World Bank Atlas Method.
http://web.worldbank.org/WBSITE/EXTERNAL/
DATASTATISTICS/0,,contentMDK:20452009,isCURL:Y,
menuPK:64133156,pagePK:64133150,piPK:64133175,
theSitePK:239419,00.html Date last accessed: March 17, 2009.
18 Weinmayr G, Weiland SK, Bjorksten B, et al. Atopic
sensitization and the international variation of asthma
symptom prevalence in children. Am J Respir Crit Care Med
2007; 176: 565–574.
19 Miller MR, Hankinson J, Brusasco V, et al. Standardisation
of spirometry. Eur Respir J 2005; 26: 319–338.
20 Riedler J, Reade T, Dalton M, Holst D, Robertson C.
Hypertonic saline challenge in an epidemiologic survey of
asthma in children. Am J Respir Crit Care Med 1994; 150:
1632–1639.
21 Richardson DB, Rzehak P, Klenk J, Weiland SK. Analyses
of case–control data for additional outcomes. Epidemiology
2007; 18: 441–445.
22 Normand SL. Meta-analysis: formulating, evaluating,
combining, and reporting. Stat Med 1999; 18: 321–359.
23 Kull I, Wickman M, Lilja G, Nordvall SL, Pershagen G.
Breast feeding and allergic diseases in infants – a
prospective birth cohort study. Arch Dis Child 2002; 87:
478–481.
24 Wright AL, Holberg CJ, Taussig LM, Martinez FD. Factors
influencing the relation of infant feeding to asthma and
recurrent wheeze in childhood. Thorax 2001; 56: 192–197.
25 Oddy WH, Holt PG, Sly PD, et al. Association between
breast feeding and asthma in 6 year old children:
findings of a prospective birth cohort study. BMJ 1999;
319: 815–819.
26 Frank PI, Morris JA, Hazell ML, Linehan MF, Frank TL.
Long term prognosis in preschool children with wheeze:
longitudinal postal questionnaire study 1993–2004. BMJ
2008; 336: 1423–1426.
27 Oddy WH, de Klerk NH, Sly PD, Holt PG. The effects of
respiratory infections, atopy, and breastfeeding on childhood asthma. Eur Respir J 2002; 19: 899–905.
28 Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial
virus in early life and risk of wheeze and allergy by age
13 years. Lancet 1999; 354: 541–545.
29 Matheson MC, Erbas B, Balasuriya A, et al. Breastfeeding and atopic disease: A cohort study from childhood to middle age. J Allergy Clin Immunol 2007; 120:
1051–1057.
30 Bottcher MF, Jenmalm MC, Garofalo RP, Bjorksten B.
Cytokines in breast milk from allergic and nonallergic
mothers. Pediatr Res 2000; 47: 157–162.
EUROPEAN RESPIRATORY JOURNAL
VOLUME 33 NUMBER 5
(London, UK); W. Cookson (Oxford, UK); H. Williams
(Nottingham, UK); I. Asher, P. Ellwood, E. Mitchell and
A. Stewart (Auckland, New Zealand); J. Crane, R. Beasley and
N. Pearce (Wellington, New Zealand); B. Björkstén (Stockholm,
Sweden); B. Brunekreef (Utrecht, the Netherlands); S. Foliaki
(Nuku’alofa, Kingdom of Tonga); L. Garcı́a-Marcos (Murcia,
Spain); U. Keil and E. von Mutius (Munich, Germany);
S.K. Weiland{ (Ulm, Germany); C. Lai and G. Wong (Hong
Kong, China); J. Mallol (Santiago, Chile); S. Montefort (Naxxar,
Malta); J. Odhiambo (Nairobi, Kenya); C. Robertson (Parkville,
Australia).
The agencies funding the field work are listed elsewhere [15].
1001
c
BREASTFEEDING, ASTHMA, LUNG FUNCTION IN ISAAC II
31 Duchen K, Bjorksten B. Polyunsaturated n-3 fatty acids and
the development of atopic disease. Lipids 2001; 36: 1033–1042.
32 Jeppesen DL, Hasselbalch H, Lisse IM, Ersboll AK,
Engelmann MD. T-lymphocyte subsets, thymic size and
breastfeeding in infancy. Pediatr Allergy Immunol 2004; 15:
127–132.
1002
VOLUME 33 NUMBER 5
G. NAGEL ET AL.
33 Sinha A, Madden J, Ross-Degnan D, Soumerai S, Platt R.
Reduced risk of neonatal respiratory infections among
breastfed girls but not boys. Pediatrics 2003; 112: e303.
34 von Mutius E. Influences in allergy: epidemiology and
the environment. J Allergy Clin Immunol 2004; 113:
373–379.
EUROPEAN RESPIRATORY JOURNAL